Project 4: The role of codon bias in RAS tumorigenesis
项目 4:密码子偏倚在 RAS 肿瘤发生中的作用
基本信息
- 批准号:9074410
- 负责人:
- 金额:$ 68.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-22 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAffectAllelesAnimal ModelApoptosisBase SequenceCancer EtiologyCarcinogen exposureCarcinogensCellsCharacteristicsCodon NucleotidesDevelopmentDiseaseDrosophila genusEngineeringEpidemiologyExonsFamilyFosteringFrequenciesGenesGrowthHRAS geneHumanKRAS2 geneLinkLungLung AdenomaLung NeoplasmsMalignant - descriptorMalignant NeoplasmsMessenger RNAModelingMolecularMusMutateMutationOncogenicPhenotypeProtein IsoformsProteinsPublic HealthRAS Family GeneResearchResistanceRoleSeveritiesSignal TransductionSilent MutationStagingTestingTimeTissuesTranslationsTumor BurdenUrethaneVariantactionable mutationcancer cellclinically relevantflymalignant phenotypeneoplastic cellnovelprotein expressionresponsescreeningsenescencetumortumorigenesistumorigenic
项目摘要
ABSTRACT
The RAS family of genes, comprised of KRAS, NRAS, and HRAS, are mutated in upwards of a third of
all human cancers, yielding proteins that remain in a constitutively active, oncogenic state that are well
established to cause this disease. The proteins encoded by these three genes are nearly identical,
activated by and signal through the same proteins, and capable of causing cancer in mice. Despite this
uniformity, KRAS is the most commonly mutated of the three, and the type of mutations in KRAS, as well
as the other RAS genes, varies extensively in human cancers. To understand these phenomena, we
compared the nucleotide sequence of the RAS genes, finding that KRAS has many rare codons that limit
protein expression, HRAS has many common codons that foster protein expression, while NRAS has a
mixture of rare and common codons and intermediate protein expression. Focusing on KRAS, the most
commonly mutated RAS gene, we show that introducing silent mutations to convert rare codons to
common in one exon of this gene reduced both the number of lung tumors and the mutations detected in
Kras of mice exposed to a carcinogen. To determine the mechanism responsible for this result, in aim 1
we will activate an inducible oncogenic Kras gene with common codons in the lungs of mice to identify
the stage of tumorigenesis sensitive to perturbing the inherent rare codon bias of Kras. Once identified,
we will then hone in on the cellular feature changed, and in turn, the molecular response underlying this
effect. Converting rare codons to common also altered the type of oncogenic mutations recovered in
Kras after carcinogen exposure. To determine the underlying mechanism, in aim 2 we will similarly
engineer mice with an inducible Kras gene encoded by common versus native codons with different
oncogenic mutations. As above, these Kras alleles will be activated in the lungs of mice to determine
how different oncogenic mutations in the backdrop of altered codon usage impacts tumorigenesis, tumor
cell characteristics, and cellular signaling. Completion of these two aims will elucidate the mechanism by
which codon bias influences the frequency and type of mutations arising in Kras during tumorigenesis.
Despite the advantage afforded to Kras by rare codons in early tumorigenesis, we show that established
cancer cells overcome the poor translation of Kras mRNA imposed by rare codons to increase Kras
protein expression, which was linked to increased tumorigenic activity and resistance to
chemotherapeutics. To identify how cancer cells achieve this feat, we screened for and identified codon-
dependent modifiers of oncogenic Ras in the model organism Drosophila. We will capitalize on these
candidate modifiers in aim 3 to elucidate how cancer cells overcome poor translation of Kras, and in turn,
whether such changes promote more malignant phenotypes. In summary, this research will reveal how
this novel feature of KRAS, codon bias, impacts tumorigenesis.
摘要
RAS基因家族,包括KRAS、NRAS和HRAS,在超过三分之一的人中发生突变。
所有人类癌症,产生的蛋白质保持在组成性活性,致癌状态,
导致了这种疾病。这三个基因编码的蛋白质几乎相同,
由相同的蛋白质激活并通过相同的蛋白质发出信号,能够在小鼠中引起癌症。尽管如此
KRAS是三者中最常见的突变,KRAS中的突变类型也是如此。
与其他RAS基因一样,在人类癌症中差异很大。为了理解这些现象,我们
比较了RAS基因的核苷酸序列,发现KRAS有许多罕见的密码子,
蛋白质表达,HRAS有许多共同的密码子,促进蛋白质表达,而NRAS有一个共同的密码子。
罕见和常见密码子的混合物和中间蛋白质表达。专注于KRAS,
通常突变的RAS基因,我们表明,引入沉默突变转换罕见的密码子,
在该基因的一个外显子中存在一个共同的突变,这既减少了肺肿瘤的数量,也减少了在肺癌中检测到的突变。
暴露于致癌物的小鼠的Kras。为了确定造成这一结果的机制,在目标1中
我们将激活小鼠肺中具有共同密码子的可诱导致癌Kras基因,
肿瘤发生的阶段对扰乱Kras的固有稀有密码子偏好敏感。一旦确定,
然后,我们将深入研究细胞特征的变化,进而研究其背后的分子反应。
效果将罕见密码子转换为常见密码子也改变了在基因组中恢复的致癌突变的类型。
致癌物暴露后的Kras。为了确定潜在的机制,在目标2中,我们将类似地
用可诱导的Kras基因改造小鼠,所述基因由具有不同的共同密码子与天然密码子编码
致癌突变如上所述,这些Kras等位基因将在小鼠的肺中被激活,以确定
在密码子使用改变的背景下,不同的致癌突变如何影响肿瘤发生,
细胞特性和细胞信号传导。这两个目标的完成将阐明该机制,
该密码子偏好性影响肿瘤发生过程中Kras突变的频率和类型。
尽管在早期肿瘤发生中稀有密码子为Kras提供了优势,但我们发现,
癌细胞克服了由稀有密码子施加的Kras mRNA的差翻译,以增加Kras
蛋白质表达,这与增加的致瘤活性和耐药性有关。
化疗药物为了确定癌细胞是如何实现这一壮举的,我们筛选并鉴定了密码子-
模式生物果蝇中致癌Ras的依赖性修饰物。我们将利用这些
目的3中的候选修饰剂,以阐明癌细胞如何克服Kras的不良翻译,并且反过来,
这些变化是否会促进更多的恶性表型。总之,这项研究将揭示如何
KRAS的这种新特征,密码子偏好性,影响肿瘤发生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTOPHER M COUNTER其他文献
CHRISTOPHER M COUNTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTOPHER M COUNTER', 18)}}的其他基金
Proteasomal recruiters of PAX3-FOXO1 Designed via Sequence-Based Generative Models
通过基于序列的生成模型设计的 PAX3-FOXO1 蛋白酶体招募剂
- 批准号:
10826068 - 财政年份:2023
- 资助金额:
$ 68.71万 - 项目类别:
Screening for Cys-Reactive Ligands to Target PAX3-FOXO1
筛选针对 PAX3-FOXO1 的 Cys 反应性配体
- 批准号:
10611002 - 财政年份:2022
- 资助金额:
$ 68.71万 - 项目类别:
Genetic dissection of oncogenic RAS-driven tumor initiation in vivo
体内致癌 RAS 驱动的肿瘤发生的基因剖析
- 批准号:
10415753 - 财政年份:2022
- 资助金额:
$ 68.71万 - 项目类别:
Genetic dissection of oncogenic RAS-driven tumor initiation in vivo
体内致癌 RAS 驱动的肿瘤发生的基因剖析
- 批准号:
10610444 - 财政年份:2022
- 资助金额:
$ 68.71万 - 项目类别:
Defining and targeting the molecular vulnerabilities of the PAX3-FOXO1 protein in rhabdomyosarcoma
横纹肌肉瘤中 PAX3-FOXO1 蛋白的分子脆弱性的定义和靶向
- 批准号:
10221086 - 财政年份:2020
- 资助金额:
$ 68.71万 - 项目类别:
Defining and targeting the molecular vulnerabilities of the PAX3-FOXO1 protein in rhabdomyosarcoma
横纹肌肉瘤中 PAX3-FOXO1 蛋白的分子脆弱性的定义和靶向
- 批准号:
10221081 - 财政年份:2020
- 资助金额:
$ 68.71万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 68.71万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 68.71万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 68.71万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 68.71万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 68.71万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 68.71万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 68.71万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 68.71万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 68.71万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 68.71万 - 项目类别:
Grant-in-Aid for Early-Career Scientists